Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02096354
Title A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer
Acronym ROCKET
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors EpicentRx, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UCSD Moores Cancer Center La Jolla California 92093 United States Details
Stanford University Stanford California 94305 United States Details
Kaiser Permanete Honolulu Hawaii 96819 United States Details
Walter Reed National Military Medical Center Bethesda Maryland 20889 United States Details
Aquilino Cancer Center, Maryland Oncology and Hematology PA Rockville Maryland 20850 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field